Trials / Terminated
TerminatedNCT00437242
Odiparcil QT Definitive Study
A Study to Evaluate the Effect of Repeat Oral Doses of Odiparcil on Cardiac Conduction as Assessed by 12-lead Electrocardiogram Compared to Placebo and a Single Oral Dose of Moxifloxacin.
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (planned)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study is being completed to demonstrate the lack of effect of repeat dosing with Odiparcil on the QTc interval.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Odiparcil |
Timeline
- Start date
- 2006-10-01
- First posted
- 2007-02-19
- Last updated
- 2012-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00437242. Inclusion in this directory is not an endorsement.